Klemp Walter V reported MBRX

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001437749-26-035615

Machine-readable

Structured copy

Timestamps

Event (reported)

Nov 4, 2026

Published

Nov 6, 2026

Ingested by INSIDER

Nov 6, 22:10 UTC

Last re-read

Nov 7, 15:04 UTC

Extracted facts

Filer

Klemp Walter V

Role

Director, CEO and President

Transaction

Tax withholdingAs filed: “F”

Asset

Moleculin Biotech, Inc.

Ticker

MBRX

Shares

14

Price per share

$8.46

Value

$118

Execution date (reported)

Nov 4, 2026

Owned after transaction

36.2K shares

Days from execution to publication

2

Calculation

What this establishes

Klemp Walter V filed this Form 4 reporting a tax withholding of MBRX on Nov 4, 2026. It became public on Nov 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director, CEO and President

Klemp Walter Vcik:0000938419

Issuer

Moleculin Biotech, Inc.cik:0001659617

Revision history · 0

No field has changed since this record was first ingested.